Company Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange 12:31:47 2024-03-18 pm EDT 5-day change 1st Jan Change
85.53 CHF -0.13% Intraday chart for Novartis AG -3.68% +0.78%

Business Summary

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows:

- pharmaceutical products (81.7%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal disorders, cancers, central nervous system disorders, hormone imbalances, etc.;

- generic drugs (18.3%; Sandoz).

Net sales are distributed geographically as follows: Europe (36.5%), the United States (34.9%), Asia/Africa/Australasia (20.9%), Canada and Latin America (7.7%).

Number of employees: 76,057

Sales per Business

CHF in Million2022Weight2023Weight Delta
Established Brands
30.0 %
- - 12,238 30.0 % -
Oncology
29.9 %
- - 12,213 29.9 % -
Immunology
17.2 %
- - 7,008 17.2 % -
Cardiovascular, Renal and Metabolic
14.1 %
- - 5,743 14.1 % -
Neuroscience
8.9 %
- - 3,633 8.9 % -

Sales per region

CHF in Million2022Weight2023Weight Delta
United States
39.5 %
16,860 34.9 % 16,139 39.5 % -4.28%
Europe
18.9 %
10,469 21.7 % 7,704 18.9 % -26.41%
Asia/Africa/Australasia
9.1 %
4,975 10.3 % 3,700 9.1 % -25.63%
Germany
7.4 %
4,086 8.5 % 3,026 7.4 % -25.94%
China
7.2 %
2,987 6.2 % 2,936 7.2 % -1.73%
Canada and Latin America
7.0 %
3,709 7.7 % 2,854 7.0 % -23.04%
Japan
4.2 %
2,106 4.4 % 1,729 4.2 % -17.90%
France
3.8 %
2,156 4.5 % 1,572 3.8 % -27.09%
Switzerland
2.9 %
926 1.9 % 1,175 2.9 % +26.88%

Managers

Managers TitleAgeSince
Chief Executive Officer 48 04-12-31
Director of Finance/CFO 59 02-12-31
Chief Tech/Sci/R&D Officer 62 22-05-15
Chief Operating Officer 57 17-03-31
Compliance Officer 56 18-11-30
Public Communications Contact 63 03-12-31
Corporate Officer/Principal - 13-07-31
Comptroller/Controller/Auditor 61 22-04-30
Corporate Officer/Principal - -
Human Resources Officer 56 21-08-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 65 20-02-27
Chairman 68 12-12-31
Director/Board Member 60 23-03-06
Director/Board Member 63 20-02-27
Director/Board Member 59 15-12-31
Director/Board Member 65 12-12-31
Director/Board Member 66 14-12-31
Director/Board Member 68 19-02-27
Director/Board Member 63 17-02-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,277,477,752 1,965,291,633 ( 86.29 %) 233,443,766 ( 10.25 %) 86.29 %

Shareholders

NameEquities%Valuation
227,771,554 10.00 % 23 148 M CHF
Sandoz Family Foundation
3.914 %
89,135,960 3.914 % 9 059 M CHF
UBS Asset Management Switzerland AG
3.003 %
68,391,910 3.003 % 6 951 M CHF
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.2895 %
6,593,896 0.2895 % 670 M CHF
State Street Global Advisors Ltd.
0.2301 %
5,241,340 0.2301 % 533 M CHF
MFS International (UK) Ltd.
0.1718 %
3,912,404 0.1718 % 398 M CHF
UBS AG (Investment Management)
0.1713 %
3,902,170 0.1713 % 397 M CHF
La Mondiale SAM (Investment Portfolio)
0.1707 %
3,888,630 0.1707 % 395 M CHF
Union Investment Privatfonds GmbH
0.1595 %
3,632,402 0.1595 % 369 M CHF
Sjunde AP-fonden
0.1551 %
3,533,133 0.1551 % 359 M CHF
NameEquities%Valuation
Dodge & Cox
0.5781 %
13,165,538 0.5781 % 1 329 M CHF
PRIMECAP Management Co.
0.5667 %
12,905,697 0.5667 % 1 303 M CHF
Eaton Vance Management
0.3114 %
7,092,253 0.3114 % 716 M CHF
Dimensional Fund Advisors LP
0.2669 %
6,078,175 0.2669 % 614 M CHF
Loomis, Sayles & Co. LP
0.2639 %
6,009,900 0.2639 % 607 M CHF
Fiduciary Trust Company International
0.2598 %
5,915,750 0.2598 % 597 M CHF
U.S. Trust Company of Delaware
0.2309 %
5,258,331 0.2309 % 531 M CHF
Wellington Management Co. LLP
0.2084 %
4,746,599 0.2084 % 479 M CHF
Wells Fargo Bank NA
0.1754 %
3,994,934 0.1754 % 403 M CHF
The Ayco Co. LP
0.1553 %
3,535,902 0.1553 % 357 M CHF
NameEquities%Valuation
LUKB Expert Fondsleitung AG
-
64,694 - 7 M CHF
ATP Fondsmaeglerselskab A/S
-
46,082 - 5 M CHF
Swiss Rock Asset Management AG
-
19,614 - 2 M CHF
Niederer & Partners AG
-
5,300 - 538 457 CHF
JPMorgan Asset Management (China) Co Ltd.
-
2,652 - 269 432 CHF
Liontrust Portfolio Management Ltd.
-
474 - 48 156 CHF

Holdings

NameEquities%Valuation
227,771,554 10.00% 23,148,345,591 $
18,524,209 4.30% 577,678,384 $
17,450,680 70.68% 198,486,303 $
12,307,692 8.15% 29,292,307 $
2,642,762 6.55% 26,797,607 $
5,908,089 6.18% 23,396,032 $
1,713,521 4.68% 20,390,900 $
1,739,130 4.78% 7,712,572 $
413,577 6.51% 7,651,175 $
4,336,759 3.27% 1,561,233 $

Company contact information

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 1111

http://www.novartis.com
address Novartis AG(NOVN)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Investment Managers
Pharmaceuticals: Major
Investment Managers
Pharmaceuticals: Major
Finance/Rental/Leasing
Novartis Finance SA
Finance/Rental/Leasing
Pharmaceuticals: Major
Pharmaceuticals: Major

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
96.46 USD
Average target price
109 USD
Spread / Average Target
+13.00%
Consensus